Chemotherapy for metastatic NSCLC: Current status and future direction

Ramaswamy Govindan

doi:10.1038/ncponc0169

Chemotherapy for metastatic NSCLC: Current status and future direction

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	238-239
Number of pages	2
Journal	Nature Clinical Practice Oncology
Volume	2
Issue number	5
DOIs	https://doi.org/10.1038/ncponc0169
State	Published - May 2005

Keywords

Chemotherapy
NSCLC
Response
Survival
Toxicity

Access to Document

10.1038/ncponc0169

Cite this

@article{e22ee745767c404687a88c4c9a7c8dfd,

title = "Chemotherapy for metastatic NSCLC: Current status and future direction",

keywords = "Chemotherapy, NSCLC, Response, Survival, Toxicity",

author = "Ramaswamy Govindan",

year = "2005",

month = may,

doi = "10.1038/ncponc0169",

language = "English",

volume = "2",

pages = "238--239",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",

number = "5",

}

TY - JOUR

T1 - Chemotherapy for metastatic NSCLC

T2 - Current status and future direction

AU - Govindan, Ramaswamy

PY - 2005/5

Y1 - 2005/5

KW - Chemotherapy

KW - NSCLC

KW - Response

KW - Survival

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=20444456290&partnerID=8YFLogxK

U2 - 10.1038/ncponc0169

DO - 10.1038/ncponc0169

M3 - Short survey

C2 - 16264956

AN - SCOPUS:20444456290

SN - 1743-4254

VL - 2

SP - 238

EP - 239

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

IS - 5

ER -

Chemotherapy for metastatic NSCLC: Current status and future direction

Keywords

Access to Document

Other files and links

Cite this